source
- BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026BioSpace introduced a new IPO dashboard that monitors U.S. biotech companies that went public in 2026. The tool will be refreshed weekly with the latest closing prices and will add any newly liste…
- Why a fresh approach to targeting G protein-coupled receptors could treat a rare eye cancerResearchers found that only by targeting both the G protein-coupled receptor and its mutated internal molecular switch can uveal melanoma cell signaling be disrupted.Fierce Biotech · 19h ago↗ source
- Bayer's Sunharbo becomes first FDA-approved factor XIa inhibitor blood thinner